Top Cost-Containment Stories
Consistent GLP-1 use significantly slows medical cost growth for employers
By Alan GoforthNotably, female GLP-1 users experienced a 47% reduction in hospitalizations for major cardiovascular events; approximately 50% lower incidence of ovarian cancer; and a 14% lower incidence of breast cancer compared to female non-users.




